HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dr. Bronner’s Urges NAD/NARB To Refer Fair Trade USA To Regulators

This article was originally published in The Rose Sheet

Executive Summary

Unsatisfied with Fair Trade USA’s response to the National Advertising Review Board’s latest ruling, which advised the certifier to require percentage breakdowns for fair-trade ingredients on personal-care products, Dr. Bronner’s Magic Soaps asks that the case be referred to regulatory authorities.

You may also be interested in...



Fair Trade USA’s Draft Certification Policy Riles Organic Community

The Organic Consumer Association’s Fair World Project opposes Fair Trade USA’s draft policy for multi-ingredient products, which it says panders to big business and represents a step backward even from the group’s previously contested standards. Dr Bronner’s Magic Soaps is preparing to file a new complaint with the National Advertising Division.

Dr. Bronner’s Joins WFTO, Takes Jab At Fair Trade USA

Dr. Bronner’s Magic Soaps joins the World Fair Trade Organization, which recognizes “fully committed” fair-trade brands, it says. The organic personal-care maker seizes the opportunity to contrast WFTO’s program with that of Fair Trade USA.

In Brief

The European Commission has amended EU REACH chemicals law so that SMEs pay less in registration fees, while larger companies pay more. More news in brief.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018338

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel